Circular

Regenx Announces Rights Offering and Share Consolidation

Retrieved on: 
Tuesday, March 26, 2024

Assuming the exercise of all Rights, the Rights Offering will raise gross proceeds of up to $2,966,316.

Key Points: 
  • Assuming the exercise of all Rights, the Rights Offering will raise gross proceeds of up to $2,966,316.
  • Complete details of the Rights Offering are set out in the Circular and the rights offering notice (the ‎‎“Notice”), which are filed under the Corporation’s profile at www.sedarplus.ca.
  • Registered Shareholders who wish to exercise their Rights must ‎complete and forward the Rights DRS Advice and subscription form, together with applicable funds, to Computershare Investor ‎Services Inc., the depositary for the Rights Offering, on or before the Expiry Time of the Rights Offering.
  • The proposed basis for the share consolidation is one (1) post-consolidation Common Share for up to every two (2) pre-consolidation Common Shares (the "Share Consolidation").

Maniv Announces Third Early-stage Venture Fund of $140m to Accelerate the Decarbonization and Digitization of Global Transportation

Retrieved on: 
Thursday, April 4, 2024

Investing since 2016, Maniv was among the first institutional investors to articulate a global, early-stage investment strategy focused on the intersection between mobility, transportation and energy.

Key Points: 
  • Investing since 2016, Maniv was among the first institutional investors to articulate a global, early-stage investment strategy focused on the intersection between mobility, transportation and energy.
  • Simultaneously, the market-driven decarbonization of transportation – representing as much as one quarter of global GHG emissions – is at an inflection point.
  • Maniv’s third fund is backed by institutional capital, high-net-worth individuals, and a consortium of industry leaders at the forefront of the transportation sector.
  • “Our third fund builds on two decades in the trenches of the global mobility ecosystem,” said Michael Granoff, the firm’s Managing Partner.

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Tricon Shareholders Vote FOR the Arrangement Resolution Approving Transaction with Blackstone Real Estate

Retrieved on: 
Monday, March 18, 2024

Company Shareholders are reminded that the deadline to vote is fast approaching.

Key Points: 
  • Company Shareholders are reminded that the deadline to vote is fast approaching.
  • Company Shareholders are encouraged to submit their vote in advance by completing the instructions in their form of proxy (in the case of registered Company Shareholders) or voting instruction form (in the case of non-registered Company Shareholders.
  • Visit Tricon’s Investor Relations website at www.triconresidential.com to access materials and information related to the upcoming Special Meeting.
  • Details of the Special Meeting and how Company Shareholders or their duly appointed proxyholders can attend, access, participate in and vote at the Special Meeting are set out in the Circular.

NEW GOLD PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2024 RESULTS AND CONFERENCE CALL

Retrieved on: 
Wednesday, April 3, 2024

TORONTO, April 3, 2024 /PRNewswire/ - New Gold Inc. ("New Gold" or the "Company") (TSX and NYSE American: NGD) is providing notice that it will release its first quarter 2024 operational and financial results after market close on Tuesday, April 30, 2024.

Key Points: 
  • TORONTO, April 3, 2024 /PRNewswire/ - New Gold Inc. ("New Gold" or the "Company") (TSX and NYSE American: NGD) is providing notice that it will release its first quarter 2024 operational and financial results after market close on Tuesday, April 30, 2024.
  • The Company will host its first quarter 2024 earnings conference call and webcast on Wednesday, May 1, 2024 at 8:30 am Eastern Time.
  • Participants may also listen to the conference call by calling North American toll free 1-888-664-6383, or 1-416-764-8650 outside of the U.S. and Canada, passcode 48240748.
  • To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/49Ba0Hy to receive an instant automated call back.

iA Financial Group will hold its Annual Meetings on May 9 and has made available its Annual Report and the meeting documentation

Retrieved on: 
Thursday, March 28, 2024

Beneficial owners not duly appointed as proxyholders will be entitled to attend the meeting as guests but will not be entitled to vote at the meeting.

Key Points: 
  • Beneficial owners not duly appointed as proxyholders will be entitled to attend the meeting as guests but will not be entitled to vote at the meeting.
  • The 2023 Annual Report, Circular, rules of conduct applicable to the virtual meeting and Information Document are now available online at ia.ca ( https://ia.ca/investorrelations ).
  • The shareholders of iA Financial Corporation will receive the documents relating to the Annual Meeting in the coming days.
  • The Annual Report includes the Annual Management's Discussion and Analysis, the 2023 and 2022 consolidated financial statements and various other information about iA Financial Group.

CHEMISTREE TO SEEK DEBENTUREHOLDER APPROVAL FOR DEBT RESTRUCTURING

Retrieved on: 
Thursday, March 14, 2024

Pursuant to the Restructuring Transaction, the Company intends to issue an aggregate of 683,700,000 Common Shares at a price of $0.01 per Common Share to Debentureholders.

Key Points: 
  • Pursuant to the Restructuring Transaction, the Company intends to issue an aggregate of 683,700,000 Common Shares at a price of $0.01 per Common Share to Debentureholders.
  • The Company believes in its growth potential, and it believes the Restructuring Transaction is in the best interests of Debentureholders.
  • Chemistree will hold the Debentureholder Meeting to consider the Restructuring Transaction and the Trustee Authorization on April 5, 2024.
  • Each Debentureholder present in person or represented by proxy at the Debentureholder Meeting shall be entitled to one vote in respect of each $1,000 principal amount of Debentures held by such Debentureholder.

Exro Announces Filing and Mailing of Management Information Circular in Relation to the Proposed Merger with SEA Electric

Retrieved on: 
Wednesday, March 13, 2024

Exro Technologies Inc. files management information circular for proposed merger with SEA Electric Inc. (the "Transaction").

Key Points: 
  • Exro Technologies Inc. files management information circular for proposed merger with SEA Electric Inc. (the "Transaction").
  • Shareholders are encouraged to review the information circular carefully and to vote online in advance of the April 2, 2024 deadline.
  • CALGARY, AB, March 13, 2024 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO), (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean-technology company focused on developing new generation power-control electronics that expand the capabilities of electric motors and batteries, announced today the filing of its management information circular (the "Circular") with respect to the Transaction with SEA Electric Inc. ("SEA Electric").
  • "The Circular sets out the compelling case for shareholders to approve Exro's merger with SEA Electric," said Exro CEO Sue Ozdemir.

Polymetal International plc: Completion of divestment of Russian business

Retrieved on: 
Wednesday, March 13, 2024

Polymetal International plc (“Polymetal”, the “Company” or the “Group”) announces that following shareholder approval and satisfaction of all other conditions precedent, the divestment of Polymetal Group’s Russian business by way of disposal of 100 per cent of the JSC Polymetal share capital to JSC Mangazeya Plus has completed.

Key Points: 
  • Polymetal International plc (“Polymetal”, the “Company” or the “Group”) announces that following shareholder approval and satisfaction of all other conditions precedent, the divestment of Polymetal Group’s Russian business by way of disposal of 100 per cent of the JSC Polymetal share capital to JSC Mangazeya Plus has completed.
  • “We are pleased shareholders of Polymetal supported the sale of our Russian business.
  • With the transaction closed and major risks eliminated, we plan to present our new strategy and capital allocation policy in May”, said Vitaly Nesis, Group CEO.
  • Following Completion, the Polymetal Retained Group has a net cash position of approx.

Polymetal International plc: Proposed divestment of Polymetal Group’s Russian business and notice of General Meeting

Retrieved on: 
Wednesday, March 13, 2024

Polymetal International plc (“Polymetal”, the “Company” or the “Group”) announces today that it has entered into contracts for the divestment of its Russian business for an effective total consideration of approximately US$3.69 billion (the “Transaction”).

Key Points: 
  • Polymetal International plc (“Polymetal”, the “Company” or the “Group”) announces today that it has entered into contracts for the divestment of its Russian business for an effective total consideration of approximately US$3.69 billion (the “Transaction”).
  • A quick, transparent, and sanctions-compliant exit under the terms of the proposed Transaction serves the interests of all stakeholders.
  • The completion of the divestment will allow the Group to de-risk the Company’s business, deliver stable cash flows and pursue new investment opportunities.
  • The Transaction values the Russian business at approximately US$3.69 billion [1] including third-party debt and intra-group arrangements detailed in the Circular.

PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update

Retrieved on: 
Friday, March 8, 2024

The Company is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company (“Shareholders”) held on Tuesday, February 27, 2024 (the “Meeting”).

Key Points: 
  • The Company is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company (“Shareholders”) held on Tuesday, February 27, 2024 (the “Meeting”).
  • Shareholders voted in favour of each resolution put forth at the Meeting.
  • “PharmAla continues to make the important choices necessary for the future of both our business, and the Psychedelic Pharmaceuticals sector more broadly,” said Jodi Butts, Board Chair, PharmAla Biotech.
  • “We are grateful that PharmAla’s shareholders have agreed with management’s recommendations on a variety of timely corporate governance matters.